FDA NDC Directory · JSON-LD · Markdown

NEOPROFEN

NDC 55292-122 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nameibuprofen lysine
Labeler / ManufacturerRecordati Rare Diseases Inc.
Marketing categoryNew Drug Application (innovator) · App NDA021903
Dosage form / routeSOLUTION · INTRAVENOUS
Active ingredientsIBUPROFEN LYSINE (10 mg/mL)
Marketing started20060413
Package count1

External sources

Source: openFDA. Public-domain (CC0).